Efavaleukin alfa
20170104
Phase 2 small_molecule terminated
Quick answer
Efavaleukin alfa for Ulcerative Colitis is a Phase 2 program (small_molecule) at Amgen with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Amgen
- Indication
- Ulcerative Colitis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated